Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-30 18:43:12 - browse：7

Sarepta - Cambridge -AP — A logo sign outside of the headquarters of Sarepta Therapeutics in Cambridge, Mass. Kristoffer Tripplaar/Sipa via AP

Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to intervene earlier this year, according to three people with direct knowledge of the agency deliberations.

Inside the FDA office that oversees gene therapies, some staff had reached a non-binding conclusion that Sarepta’s gene therapy should be rejected, the individuals said, speaking on condition of anonymity. Peter Marks, a top FDA official and vocal advocate for faster gene therapy approvals, stepped in and directed staff to schedule a public hearing on the therapy on May 12.

Sarepta announced the scheduling of the public hearing last month, but the internal deliberations that led to it have not been previously reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Patient advocates debate FDA's accelerated approval process

WSS

Antibiotic resistance and the global rise in human conflict

GSK Flovent asthma inhalers replaced by authorized generics

New weight loss drugs work. But how can they best be used?

Feng Zhang CRISPR delivery startup lays off quarter of staff

Merck drug for rare lung condition set for approval in U.S.

Roche subsidiary Foundation Medicine opens new headquarters

focus

Wikipedia

explore

At least 13 dead in Texas as scorching temps continue

Roche subsidiary Foundation Medicine opens new headquarters

At least 13 dead in Texas as scorching temps continue

J&J to buy cancer drug developer Ambrx Biopharma

Medical leaders decry Supreme Court decision on affirmative action

Antibiotic resistance and the global rise in human conflict

United colonoscopy coverage change 'may cost lives,' doctors say

Eliminate the waiting period for sterilization covered by Medicaid

Wildfire smoke exposes gaps in outdoor worker protections

Donor acceptance rates hint at racial, gender bias in heart transplants: study

hotspot

GSK Flovent asthma inhalers replaced by authorized generics

Supreme Court mifepristone arguments center on docs' right to sue

The FDA must approve intranasal treatments for anaphylaxis

Chronically ill young patients struggle to find fertility info

States should stop sabotaging methadone treatment reform

Patient advocates debate FDA's accelerated approval process

entertainment

explore

hotspot

entertainment